Announcements Trials
Browse Landscape

Phase

Phase NA 124Phase 2 20Phase 3 10Phase 1 7Phase 1/2 3Phase 4 1Phase 2/3 1

Status

Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Nocturia 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Acupuncture Therapy × Clear all
NCT05540392 2025-10-10

An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms, Nocturia

NCT01815346 2018-01-12

Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG

M.D. Anderson Cancer Center

Phase 1/2 Terminated
4 enrolled
Breast

Bronchiolitis Obliterans Syndrome, Breast Neoplasms

NCT02168894 2016-03-08

SINF: Peripheral Neuropathy in Cancer Survivors

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn

Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡